Sign inGet started

Artal Participations S.a r.l.

Insider CIK 2048403 · LXRX Director, 10% owner · CAVA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CAVA CAVA GROUP, INC. S Sale2026-06-152026-06-173,000,000$90.30 $270.90M6,507,990SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award deriv2026-04-302026-05-08408,435— $0408,435SEC↗
LXRX LEXICON PHARMACEUTICALS, I M Exercise deriv2026-04-302026-05-08408,435— $00SEC↗
LXRX LEXICON PHARMACEUTICALS, I M Exercise2026-04-302026-05-0820,421,735— $0175,156,062SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award2026-02-172026-02-1941,290$65.00 $2.68M408,435SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award2026-02-022026-02-04367,145$65.00 $23.86M367,145SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award2026-02-022026-02-0418,553,846$1.30 $24.12M154,734,327SEC↗
LXRX LEXICON PHARMACEUTICALS, I A Award2026-02-022026-02-043,846,154$1.30 $5.00M7,362,368SEC↗
LXRX LEXICON PHARMACEUTICALS, I P Buy2026-02-022026-02-041,538,462$1.30 $2.00M1,538,462SEC↗